MD13

 CAS No.: 2758431-97-7  Cat No.: BP-400192 4.5  

MD13 is a macrophage migration inhibitory factor-directed PROTAC reported as the first potent MIF-targeting degrader. Public sources describe MD13 as inducing MIF degradation through the ubiquitin-proteasome system and inhibiting downstream signaling associated with MIF activity. Its target-recognition element engages MIF, while the other functional portion recruits cellular ubiquitination machinery through the PROTAC framework; detailed public information on the complete ternary-complex binding interface remains limited. Mechanistically, MD13 promotes degradation of MIF, reducing MIF-dependent signaling outputs and supporting cell-cycle effects in experimental cancer-cell models. It is useful for studying MIF biology, inflammatory and tumor-associated signaling, MAPK pathway modulation, target validation for non-kinase proteins, and optimization of PROTACs against cytokine-like or enzymatically atypical targets. MD13 also provides a research scaffold for comparing direct MIF inhibition with degradation-mediated loss of protein function.

MD13

Structure of 2758431-97-7

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
PROTAC
Molecular Formula
C35H35N5O8
Molecular Weight
628.82

* For research and manufacturing use only. Not for human or clinical use.

SizePriceStockQuantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

  • Comprehensive PROTAC Platform
  • Scientific Expertise & Technical Support
  • Custom Synthesis & Design Service
  • Extensive Product Coverage
  • Cutting-Edge Innovation
  • Fast Delivery & Global Support
  • 24/7 customer service
  • 100% quality assurance
Popular Publications Citing BOC Sciences Products
IUPACName
8-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-N-(4-(7-hydroxy-2-oxo-2H-benzo[e][1,3]oxazin-3(4H)-yl)phenyl)octanamide
InChI Key
HAHDZDUOFHMMEA-UHFFFAOYSA-N
SMILES
O=C1N(CC2=CC=C(C=C2O1)O)C3=CC=C(C=C3)NC(CCCCCCCNC4=C(C5=CC=C4)C(N(C5=O)C6CCC(NC6=O)=O)=O)=O
Mechanism

Target: MD13 targets macrophage migration inhibitory factor, commonly abbreviated MIF.

Binding site: Its MIF inhibitor moiety binds the enzymatic pocket of macrophage migration inhibitory factor.

Mechanism of action: MD13 is a cereblon-recruiting MIF PROTAC that connects a macrophage migration inhibitory factor ligand to pomalidomide through an optimized linker. By forming a ternary complex between MIF and CRL4CRBN, MD13 promotes ubiquitination and proteasome-dependent depletion of MIF protein. Reported cellular studies show potent MIF degradation, cell-cycle perturbation, and downstream signaling effects, supporting its use as a chemical biology probe. In targeted degradation research, MD13 enables evaluation of MIF protein dependency, degradation kinetics, pathway modulation, and differences between reversible MIF inhibition and full target removal.

Applications

• PROTAC-Mediated Kinase Degradation: MD13 is utilized in research to selectively degrade specific kinases, offering a novel approach to study kinase signaling pathways. By harnessing the ubiquitin-proteasome system, researchers can dissect complex cellular processes and gain insights into kinase-driven diseases.

• Targeted Protein Degradation in Cancer Research: MD13 serves as a powerful tool in oncology studies, enabling the targeted degradation of oncogenic proteins. This application facilitates the exploration of protein function and the development of new therapeutic strategies for cancer treatment.

• PROTAC-Based Neurodegenerative Disease Models: Researchers employ MD13 to degrade misfolded or pathogenic proteins implicated in neurodegenerative disorders. This approach aids in understanding disease mechanisms and identifying potential targets for therapeutic intervention.

• Studying Protein-Protein Interactions: MD13 is applied to investigate protein-protein interactions by selectively degrading one interaction partner, providing insights into cellular networks and signaling cascades. This method is essential for elucidating the roles of specific proteins within complex biological systems.

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Related Product Recommendations

BOC Sciences Support

Please contact us with any specific requirements and we will get back to you as soon as possible.


  • Verification code

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
Germany
Inquiry Basket